Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | MGLL | Q99685 | 1/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | PAM | P19021 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL822217 | 1.00 | DGKA (0.56) | DGKAGPR84FFAR1FFAR4MGLL | |
| SCHEMBL821826 | 1.00 | DGKA (0.56) | DGKAGPR84FFAR1FFAR4MGLL | |
| SCHEMBL275281 | 1.00 | DGKA (0.56) | DGKAGPR84FFAR1FFAR4MGLL | |
| SCHEMBL821541 | 1.00 | DGKA (0.56) | DGKAGPR84FFAR1FFAR4MGLL | |
| SCHEMBL822209 | 0.98 | DGKA (0.52) | DGKAGPR84FFAR1FFAR4MGLL | |
| SCHEMBL19768661 | 0.96 | DGKA (0.52) | DGKAGPR84FFAR1FFAR4MGLL | |
| SCHEMBL27601319 | 0.96 | DGKA (0.52) | DGKAGPR84FFAR1FFAR4MGLL | |
| SCHEMBL28003204 | 0.96 | DGKA (0.52) | DGKAGPR84FFAR1FFAR4MGLL | |
| SCHEMBL15028521 | 0.96 | DGKA (0.52) | DGKAGPR84FFAR1FFAR4MGLL | |
| SCHEMBL8065894 | 0.95 | DGKA (0.60) | DGKAGPR84FFAR1FFAR4MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 573 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4734923-A1 | CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS | L'OREAL (FR) | 2026-05-06 | — | — | EP | claimed |
| US-20250275894-A1 | STABLE FOAMED CLEANSING COMPOSITION AND METHODS OF USE | L'OREAL (FR) | 2025-09-04 | — | — | US | claimed |
| US-20250009628-A1 | CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS | L'OREAL (FR) | 2025-01-09 | — | — | US | claimed |
| EP-4487915-A2 | CAPSULE FORMULATIONS | ChemoCentryx, Inc. (US) | 2025-01-08 | — | — | EP | claimed |
| WO-2025006412-A1 | CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS | L'OREAL (FR) | 2025-01-02 | — | — | WO | claimed |
| US-20240299306-A1 | CAPSULE FORMULATIONS | CHEMOCENTRYX, INC. | 2024-09-12 | — | — | US | claimed |
| WO-2024131725-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | Shenzhen Pharmacin Co., Ltd. (CN) | 2024-06-27 | — | — | WO | claimed |
| CN-117440858-A | Plant-derived vesicles incorporating transmembrane proteins | 水通道蛋白有限公司 | 2024-01-23 | — | — | CN | claimed |
| US-20230310440-A1 | RESPIRATORY STIMULANT NASAL FORMULATIONS | ENALARE THERAPEUTICS INC. | 2023-10-05 | — | — | US | claimed |
| WO-2023192602-A2 | RESPIRATORY STIMULANT NASAL FORMULATIONS | ENALARE THERAPEUTICS INC. (US) | 2023-10-05 | — | — | WO | claimed |
| EP-0705094-B1 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | CARSON PROD CO (US) | 2000-05-24 | — | — | EP | claimed |
| EP-0705094-A4 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | AMINCO INC (US) | 1996-08-07 | — | — | EP | claimed |
| EP-0705094-A1 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | CARSON PRODUCTS COMPANY (US) | 1996-04-10 | — | — | EP | claimed |
| WO-1995000107-A1 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | AMINCO, INC. (US) | 1995-01-05 | — | — | WO | claimed |
| EP-0444178-A4 | MASCARA COMPOSITION | — | 1992-07-08 | — | — | EP | claimed |
| EP-0444178-A1 | MASCARA COMPOSITION | REVLON, INC. (US) | 1991-09-04 | — | — | EP | claimed |
| US-5006170-A | Thermal ink jet printing, binders, propellants | XEROX CORPORATION (US) | 1991-04-09 | — | — | US | claimed |
| WO-1991004006-A1 | MASCARA COMPOSITION | REVLON, INC. (US) | 1991-04-04 | — | — | WO | claimed |
| US-4988502-A | Cosmetics, pigments treated with lecithin, film forming resin, a humectant | REVLON, INC. (US) | 1991-01-29 | — | — | US | claimed |
| US-4173492-A | Method of preparing coated pigment particles and the product produced thereby | POLLARD EDWARD T | 1979-11-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250275894-A1 | STABLE FOAMED CLEANSING COMPOSITION AND METHODS OF USE | DAGLB, MGLL, LIPC | DGKA 129/4885GPR84 1787/4885FFAR1 493/4885 |
| US-20250009628-A1 | CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS | DAGLB, DSG1, CUTA | DGKA 434/4885GPR84 2562/4885FFAR1 1770/4885 |
| US-20230310440-A1 | RESPIRATORY STIMULANT NASAL FORMULATIONS | ADRA2C, MTNR1B, MTNR1A | DGKA 2929/4885GPR84 197/4885FFAR1 362/4885 |
| US-20240299306-A1 | CAPSULE FORMULATIONS | C5AR1, C1R, C5 | DGKA 4826/4885GPR84 786/4885FFAR1 479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.